Joseph J. Eron

Chair of the ACTG Network · ACTG network

Credentials: · · ·

History

Leadership and Operations Center (LOC), AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases · UM1
Contact PI · $761.4M · Univ of North Carolina Chapel Hill
2006–2027
University of North Carolina Global HIV Prevention and Treatment Clinical Trials Unit
National Institute of Allergy and Infectious Diseases · UM1
Contact PI · $71.8M · Univ of North Carolina Chapel Hill
2007–2027
The University of North Carolina Center for AIDS Research
National Institute of Allergy and Infectious Diseases · P30
Project lead · $6.8M · Univ of North Carolina Chapel Hill
2001–2026
HIV Tropism, Persistence, Inflammation and Neurocognition in Therapy Initiation
National Institute of Mental Health · P01
Project lead · $982.6K · Univ of North Carolina Chapel Hill
2018

Safety and Immune Response of BMS-936559 in HIV-Infected People Taking Combination Antiretroviral Therapy
Study chair · Completed · Phase 1
National Institute of Allergy and Infectious Diseases (NIAID)
2014–2015
Safety and Effectiveness of Raltegravir Plus Darunavir/Ritonavir in Treatment-Naive HIV-Infected Adults
Study chair · Completed · Phase 2
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
2009–2010
Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load
Study chair · Completed · Phase 2
National Institute of Allergy and Infectious Diseases (NIAID)
2007–2008
Effect of an Enfuvirtide-based Anti-HIV Drug Regimen on Latent HIV Reservoirs in Treatment Naive Adults
Study chair · Completed
National Institute of Allergy and Infectious Diseases (NIAID)
2003–2008